Paulukonis Susan T, Eckman James R, Snyder Angela B, Hagar Ward, Feuchtbaum Lisa B, Zhou Mei, Grant Althea M, Hulihan Mary M
Public Health Institute, Oakland, CA.
Emory University, Atlanta, GA.
Public Health Rep. 2016 Mar-Apr;131(2):367-75. doi: 10.1177/003335491613100221.
Population-based surveillance data from California and Georgia for years 2004 through 2008 were linked to state death record files to determine the all-cause death rate among 12,143 patients identified with sickle cell disease (SCD).
All-cause death rates, by age, among these SCD patients were compared with all-cause death rates among both African Americans and the total population in the two states. All-cause death rates were also compared with death rates for SCD derived from publicly available death records: the compressed mortality files and multiple cause of death files.
Of 12,143 patients identified with SCD, 615 patients died. The all-cause mortality rate for the SCD population was lower than the all-cause mortality rate among African Americans and similar to the total population all-cause mortality rates from birth through age 4 years, but the rate was higher among those with SCD than both the African American and total population rates from ages 5 through 74 years. The count of deceased patients identified by using population-based surveillance data (n=615) was more than twice as high as the count identified in compressed mortality files using SCD as the underlying cause of death alone (n=297).
Accurate assessment of all-cause mortality and age at death requires long-term surveillance via population-based registries of patients with accurately diagnosed SCD.
将2004年至2008年加利福尼亚州和佐治亚州基于人群的监测数据与州死亡记录档案相链接,以确定12143例确诊为镰状细胞病(SCD)患者的全因死亡率。
将这些SCD患者按年龄分组的全因死亡率与这两个州非裔美国人及总人口的全因死亡率进行比较。全因死亡率还与从公开可得的死亡记录(压缩死亡率档案和多死因档案)得出的SCD死亡率进行比较。
在12143例确诊为SCD的患者中,615例死亡。SCD人群的全因死亡率低于非裔美国人的全因死亡率,在出生至4岁年龄段与总人口的全因死亡率相似,但在5至74岁年龄段,SCD患者的死亡率高于非裔美国人和总人口的死亡率。使用基于人群的监测数据确定的死亡患者数(n = 615)比仅将SCD作为根本死因在压缩死亡率档案中确定的患者数(n = 297)高出两倍多。
准确评估全因死亡率和死亡年龄需要通过基于人群的登记系统对确诊SCD患者进行长期监测。